INB-200

N/A

Report date: 2025/05/09 15:54:04

Base Information

Drug NameINB-200

Drug Alias NameDeltEx DRIEAGD T-cell infusionINB-200

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Gamma delta T-cell therapy

Mechanisms of ActionT lymphocyte replacements6-O-methylguanine-DNA methyltransferase modulators

Targets6-O-methylguanine-DNA methyltransferase

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesIN8BIO Inc

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Alabama At Birmingham

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A